ES2156616T3 - (r)-5-bromo-n-(1-etil-4-metilhexahidro-1h-1,4-diazepan-6-il)-2-metoxi-6-metilamino-3-piridincarboxamida, procedimiento para su produccion y composicion medicinal que la contiene. - Google Patents

(r)-5-bromo-n-(1-etil-4-metilhexahidro-1h-1,4-diazepan-6-il)-2-metoxi-6-metilamino-3-piridincarboxamida, procedimiento para su produccion y composicion medicinal que la contiene.

Info

Publication number
ES2156616T3
ES2156616T3 ES96924189T ES96924189T ES2156616T3 ES 2156616 T3 ES2156616 T3 ES 2156616T3 ES 96924189 T ES96924189 T ES 96924189T ES 96924189 T ES96924189 T ES 96924189T ES 2156616 T3 ES2156616 T3 ES 2156616T3
Authority
ES
Spain
Prior art keywords
metilhexahydro
pyridincarboxamide
metoxi
etil
diazepan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96924189T
Other languages
English (en)
Inventor
Shiro Kato
Yoshimi Hirokawa
Toshiya Morie
Hiroshi Harada
Naoyuki Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dainippon Pharmaceutical Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2156616T3 publication Critical patent/ES2156616T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

ESTA INVENCION PRESENTA UN COMPUESTO EXPRESADO POR LA FORMULA (I): O UNA SAL ACEPTABLE FISIOLOGICAMENTE POR ADICION DE ACIDOS. EL COMPUESTO PRESENTADO MUESTRA UN EFECTO ANTIEMETICO EXCELENTE BASADO EN SUS POTENTES ACTIVIDADES ANTAGONISTAS DE LOS RECEPTORES S 3 DE SEROTONINA Y D 2 DE DOPAMINA, S IENDO UTIL PARA EL TRATAMIENTO O LA PROFILAXIS DE VARIOS SINTOMAS GASTROINTESTINALES QUE SE ASOCIAN CON DIVERSAS ENFERMEDADES Y CON LA ADMINISTRACION DE FARMACOS.
ES96924189T 1995-07-28 1996-07-23 (r)-5-bromo-n-(1-etil-4-metilhexahidro-1h-1,4-diazepan-6-il)-2-metoxi-6-metilamino-3-piridincarboxamida, procedimiento para su produccion y composicion medicinal que la contiene. Expired - Lifetime ES2156616T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP07212495 1995-07-28

Publications (1)

Publication Number Publication Date
ES2156616T3 true ES2156616T3 (es) 2001-07-01

Family

ID=16623612

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96924189T Expired - Lifetime ES2156616T3 (es) 1995-07-28 1996-07-23 (r)-5-bromo-n-(1-etil-4-metilhexahidro-1h-1,4-diazepan-6-il)-2-metoxi-6-metilamino-3-piridincarboxamida, procedimiento para su produccion y composicion medicinal que la contiene.

Country Status (25)

Country Link
US (1) US5945415A (es)
EP (1) EP0855397B1 (es)
KR (1) KR19990028395A (es)
CN (1) CN1096459C (es)
AT (1) ATE201021T1 (es)
AU (1) AU700635B2 (es)
BR (1) BR9609691A (es)
CA (1) CA2228056A1 (es)
CZ (1) CZ290442B6 (es)
DE (1) DE69612753T2 (es)
DK (1) DK0855397T3 (es)
ES (1) ES2156616T3 (es)
GR (1) GR3036089T3 (es)
HK (1) HK1018049A1 (es)
HU (1) HUP9901208A3 (es)
IL (1) IL122753A (es)
MX (1) MX9800620A (es)
NO (1) NO312964B1 (es)
NZ (1) NZ312799A (es)
PL (1) PL184073B1 (es)
PT (1) PT855397E (es)
RU (1) RU2156248C2 (es)
SK (1) SK282044B6 (es)
TR (1) TR199800165T1 (es)
WO (1) WO1997005129A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19650778C2 (de) * 1996-12-06 2001-01-04 Asta Medica Ag Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
ITBO20020198A1 (it) * 2002-04-12 2003-10-13 Univ Bologna Derivati 2 , 5 bis diammino 1 , 4 benzochenionici utili per il trattamento della malattia di alzheimer , metodo per la loro preparazione ed
EP1558081A4 (en) * 2003-01-13 2006-06-14 Dynogen Pharmaceuticals Inc METHOD OF TREATING FUNCTIONAL INTESTINAL DISORDERS
EP1567163B1 (en) * 2003-01-13 2007-04-11 Dynogen Pharmaceuticals Inc. Method of treating nausea, vomiting, retching or any combination thereof
ES2290741T3 (es) * 2003-04-04 2008-02-16 Dynogen Pharmaceuticals Inc. Metodo de tratamiento de trastornos del tracto urinario inferior.
WO2006105117A2 (en) * 2005-03-28 2006-10-05 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
US20120010401A1 (en) 2009-03-31 2012-01-12 Zeria Pharmaceutical Co., Ltd. Method for manufacturing 1,5-benzodiazepine derivative
CN103951624B (zh) 2010-08-26 2019-04-16 兴和株式会社 1,4-二氮杂环庚烷衍生物或其盐的制造方法
US20170253585A1 (en) * 2014-02-03 2017-09-07 Mylan Laboratories Ltd. Processes for the preparation of intermediates of raltegravir

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017573A (en) * 1988-07-29 1991-05-21 Dainippon Pharmaceutical Co., Ltd. Indazole-3-carboxylic acid derivatives
US5166341A (en) * 1988-07-29 1992-11-24 Dainippon Pharmaceutical Co., Ltd. 6-amino-1,4-hexahydro-1H-diazepine derivatives
JPH03223265A (ja) * 1990-01-26 1991-10-02 Dainippon Pharmaceut Co Ltd 環状ジアミン誘導体
JPH04210970A (ja) * 1990-01-26 1992-08-03 Dainippon Pharmaceut Co Ltd ベンズアミド誘導体及びその中間体
PT100990A (pt) * 1991-10-24 1994-01-31 Smithkline Beecham Plc Derivados de piridina e sua utilizacao como substancia terapeutica

Also Published As

Publication number Publication date
HK1018049A1 (en) 1999-12-10
PL324749A1 (en) 1998-06-08
RU2156248C2 (ru) 2000-09-20
HUP9901208A3 (en) 2002-10-28
NO312964B1 (no) 2002-07-22
NO980333L (no) 1998-03-23
IL122753A0 (en) 1998-08-16
CN1192213A (zh) 1998-09-02
PL184073B1 (pl) 2002-08-30
US5945415A (en) 1999-08-31
AU6471796A (en) 1997-02-26
AU700635B2 (en) 1999-01-07
KR19990028395A (ko) 1999-04-15
EP0855397A4 (en) 1998-12-02
NZ312799A (en) 1999-04-29
ATE201021T1 (de) 2001-05-15
EP0855397B1 (en) 2001-05-09
DK0855397T3 (da) 2001-06-25
CZ23098A3 (cs) 1998-06-17
CN1096459C (zh) 2002-12-18
TR199800165T1 (xx) 1998-06-22
SK9398A3 (en) 1998-08-05
DE69612753D1 (de) 2001-06-13
MX9800620A (es) 1998-04-30
BR9609691A (pt) 1999-03-23
EP0855397A1 (en) 1998-07-29
WO1997005129A1 (fr) 1997-02-13
HUP9901208A2 (hu) 2000-04-28
GR3036089T3 (en) 2001-09-28
CZ290442B6 (cs) 2002-07-17
NO980333D0 (no) 1998-01-26
IL122753A (en) 2000-10-31
CA2228056A1 (en) 1997-02-13
SK282044B6 (sk) 2001-10-08
PT855397E (pt) 2001-08-30
DE69612753T2 (de) 2005-07-07

Similar Documents

Publication Publication Date Title
CO4940450A1 (es) Formulaciones farmaceuticas que contienen voriconazol
NO20000572D0 (no) Indolderivater som MCP-1 reseptor antagonister
AR027608A1 (es) Derivados de azetidina, su preparacion y las composiciones farmaceuticas que los contienen
ATE297203T1 (de) Antithrombotische mitteln
ECSP055747A (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos
GT200100137A (es) Pro-drogas de derivados de 4-fenil-piridina.
BR9902086A (pt) Formulações farmacêuticas.
ES2156616T3 (es) (r)-5-bromo-n-(1-etil-4-metilhexahidro-1h-1,4-diazepan-6-il)-2-metoxi-6-metilamino-3-piridincarboxamida, procedimiento para su produccion y composicion medicinal que la contiene.
PA8452701A1 (es) Agonistas de prostaglandinas
BRPI0413676A (pt) composto, e, composição farmacêutica
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
DK1040119T3 (da) Hemiasterlinanaloger
SE9901077D0 (sv) Novel use
BR9507231A (pt) Uso de derivados de ácido carboxílico para a produção de drogas
SE9801494D0 (sv) Novel use
CO4940448A1 (es) Modificacion a cristal de una sustancia de medicamento
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
ES2189072T3 (es) Nuevo benzo-cicloalquenos heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
SV1999000075A (es) Derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenemetil)-cefemos
DE69827614D1 (de) Chinoxalindionen
BR9809313A (pt) Compostos, promedicamento, medicamento, processo para a sua preparação e utilização dos mesmos
ES2164168T3 (es) Antagonistas de receptores de fibrinogeno que tienen residuos de beta-aminoacido sustituidos y composiciones farmaceuticas que comprenden los mismos.
GT199900027A (es) Composiciones farmacèuticas que contienen en asociaciòn un antagonista selectivo de los receptores v1adelaarginina-vasopresina y un antogonista selectivo de los receptores v2 de la arginina-vasopresina.
FI950209A0 (fi) Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 855397

Country of ref document: ES